Our research priorities
We are currently funding research into a wide range of conditions including neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease, epilepsy, stroke, brain tumours, Motor Neurone Disease and ataxia.
In 2016, our Scientific Advisory Panel identified three priority areas where they felt research investment was most needed. In each of these three areas, set out below, they highlighted a large unmet patient need coupled with lack of current research investment.
Acquired brain damage
Acquired brain damage is caused by an injury to the brain after birth. Such injury may be traumatic or non-traumatic.
There are around 350,000 hospital admissions every year in the UK relating to acquired brain injuries. For many people with severe injuries, long-term rehabilitation is necessary to maximise function and independence.
We are funding research to advance understanding of how to promote repair of the brain. This may be through behavioural interventions that stimulate recovery, or medical interventions, or a combination of both.
11,000 people are diagnosed with a brain tumour every year in the UK.
With more than 130 different types of brain tumour, which may all present with different types of symptoms, they are difficult to diagnose and exceptionally difficult to treat.
We want to improve the outlook for people with brain tumours by funding research that takes forward our understanding of the mechanisms underlying tumour development and helps develop better ways to diagnose and treat these tumours.
Headache and facial pain
Headache has been described as the most common medical complaint known to man. There are hundreds of different types of headache and facial pain disorders, ranging enormously in severity and in the impact that they have on people’s lives.
We want to improve people’s lives by funding research that addresses the causes and mechanisms of headache and facial pain, and advances diagnosis and treatment of these disorders.